FLT3-ITD confers resistance to the PI3K/Akt pathway inhibitors by protecting the mTOR/4EBP1/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia.

Nogami A, Oshikawa G, Okada K, Fukutake S, Umezawa Y, Nagao T, Kurosu T, Miura O
Oncotarget. 2015 Apr 20;6(11):9189-205. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.